Core Scientific (CORZ) Receivables (2021 - 2025)

Core Scientific (CORZ) has 5 years of Receivables data on file, last reported at $1.0 million in Q1 2025.

• Quarterly Receivables fell 8.04% year-over-year to $1.0 million in Q1 2025, while the trailing twelve-month figure through Mar 2025 was $1.0 million (down 8.04% YoY) and the FY2024 annual result came in at $1.0 million, up 2.4% from the prior year.
• Receivables eased to $1.0 million in Q1 2025 per CORZ's latest filing, from $1.0 million in the prior quarter.
• The five-year high for Receivables was $6.2 million in Q3 2024, with the low at $175000.0 in Q1 2023.
• Average Receivables over 5 years is $1.9 million, with a median of $1.1 million recorded in 2023.
• Year-over-year, Receivables slumped 84.72% in 2022 and surged 532.57% in 2024.
• Core Scientific's Receivables stood at $1.7 million in 2021, then tumbled by 84.72% to $257000.0 in 2022, then jumped by 289.49% to $1.0 million in 2023, then gained by 2.4% to $1.0 million in 2024, then decreased by 0.68% to $1.0 million in 2025.
• Business Quant data shows CORZ's Receivables at $1.0 million in Q1 2025, $1.0 million in Q4 2024, and $6.2 million in Q3 2024.